LESLIE ROSENBERG: Open Payments
NPI 1235428905 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 44 payments from 15 companies in 2025. Trend: 2023 $1,153 · 2024 $877 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $182 |
| Novo Nordisk Inc | 8 | $173 |
| Teva Pharmaceuticals USA, Inc. | 6 | $128 |
| Janssen Pharmaceuticals, Inc | 2 | $75 |
| ABBVIE INC. | 4 | $74 |
| Abbott Laboratories | 3 | $56 |
| PFIZER INC. | 3 | $51 |
| Dexcom, Inc. | 1 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Amgen Inc. | 2 | $33 |
Products named: AUSTEDO XR, AIRSUPRA, Ozempic, SPRAVATO, FREESTYLE LIBRE 3, BREZTRI, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across PA — which companies pay providers there.
